Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Welch

Showing results (691-700 of 797) with videos related to

Pageof 80
Sort By:
Clinical & Experimental Metastasis|January 14, 2012
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosisLeah M Cook, Xuemei Cao, Alexander E Dowell, et al.
The Journal of Infectious Diseases|June 2, 2019
Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon ParticlesMarkus H Kainulainen, Jessica R Spengler, Stephen R Welch, et al.
Mbio|March 17, 2022
Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus DiseaseStephen R Welch, Jessica R Spengler, Jessica R Harmon, et al.
The Journal of Infectious Diseases|February 29, 2020
Inhibition of Nipah Virus by Defective Interfering ParticlesStephen R Welch, Natasha L Tilston, Michael K Lo, et al.
International Journal of Cancer|December 29, 2005
Selenium binding protein 1 in ovarian cancerKuan-Chun Huang, Dong Choon Park, Shu-Kay Ng, et al.
The Biochemical Journal|June 12, 2010
Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapyAnne R Diers, Brian P Dranka, Karina C Ricart, et al.
Virology|June 20, 2017
Sensitivity to BST-2 restriction correlates with Orthobunyavirus host rangeMariana Varela, Ilaria M Piras, Catrina Mullan, et al.
The Journal of Infectious Diseases|November 21, 2019
Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster ModelSarah C Genzer, Stephen R Welch, Florine E M Scholte, et al.
Journal of Clinical Monitoring and Computing|March 18, 2025
Reliability of an all-in-one wearable sensor for continuous vital signs monitoring in high-risk patients: the NIGHTINGALE clinical validation studyMartine J M Breteler, Ellen Leigard, Lisa C Hartung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2005
High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trialR C Coombes, A Howell, M Emson, et al.
Pageof 80

Showing results (691-700 of 797) with videos related to

Sort By:
Pageof 80
Clinical & Experimental Metastasis|January 14, 2012
Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosisLeah M Cook, Xuemei Cao, Alexander E Dowell, et al.
The Journal of Infectious Diseases|June 2, 2019
Protection From Lethal Lassa Disease Can Be Achieved Both Before and After Virus Exposure by Administration of Single-Cycle Replicating Lassa Virus Replicon ParticlesMarkus H Kainulainen, Jessica R Spengler, Stephen R Welch, et al.
Mbio|March 17, 2022
Defective Interfering Viral Particle Treatment Reduces Clinical Signs and Protects Hamsters from Lethal Nipah Virus DiseaseStephen R Welch, Jessica R Spengler, Jessica R Harmon, et al.
The Journal of Infectious Diseases|February 29, 2020
Inhibition of Nipah Virus by Defective Interfering ParticlesStephen R Welch, Natasha L Tilston, Michael K Lo, et al.
International Journal of Cancer|December 29, 2005
Selenium binding protein 1 in ovarian cancerKuan-Chun Huang, Dong Choon Park, Shu-Kay Ng, et al.
The Biochemical Journal|June 12, 2010
Modulation of mammary cancer cell migration by 15-deoxy-delta(12,14)-prostaglandin J(2): implications for anti-metastatic therapyAnne R Diers, Brian P Dranka, Karina C Ricart, et al.
Virology|June 20, 2017
Sensitivity to BST-2 restriction correlates with Orthobunyavirus host rangeMariana Varela, Ilaria M Piras, Catrina Mullan, et al.
The Journal of Infectious Diseases|November 21, 2019
Alterations in Blood Chemistry Levels Associated With Nipah Virus Disease in the Syrian Hamster ModelSarah C Genzer, Stephen R Welch, Florine E M Scholte, et al.
Journal of Clinical Monitoring and Computing|March 18, 2025
Reliability of an all-in-one wearable sensor for continuous vital signs monitoring in high-risk patients: the NIGHTINGALE clinical validation studyMartine J M Breteler, Ellen Leigard, Lisa C Hartung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2005
High dose chemotherapy and autologous stem cell transplantation as adjuvant therapy for primary breast cancer patients with four or more lymph nodes involved: long-term results of an international randomised trialR C Coombes, A Howell, M Emson, et al.
Pageof 80